Queen Mary's Centre for Predictive in vitro Models

The Queen Mary University of London Centre for Predictive in vitro Models (CPM) is a world-leading research and innovation hub dedicated to advancing the use of complex in vitro models to predict human disease and therapeutic responses. The Centre brings together over 70 academic staff with multidisciplinary expertise in cell biology, tissue engineering, pharmacology, and computational modelling, working collaboratively to develop and apply cutting-edge in vitro models that are capable of simulating human biology in ways that traditional models cannot. At its core, CPM aims to facilitate the implementation of predictive in vitro models across a broad range of disciplines, driving forward the highest quality discovery science while accelerating the delivery of safe and effective therapeutics. The Centre's vision is to provide transformative solutions that bridge the gap between laboratory-based research and real-world clinical applications. This is achieved through the development of sophisticated, high-fidelity in vitro models that can better mimic human physiology, improve drug development processes, and reduce reliance on animal testing. The CPM's expertise spans research, training, and translation, equipping the next generation of scientists with the skills needed to harness these innovative models. The Centre actively engages in public engagement and policy shaping, working with regulators, policymakers, and the public to influence the future of biomedical science and promote the adoption of in vitro technologies in research and healthcare. The Centre’s collaborative approach fosters strong partnerships with industry leaders, healthcare providers, and academic institutions, positioning CPM at the forefront of in vitro model development. By combining interdisciplinary expertise with cutting-edge technology, the Centre is accelerating the transition of predictive in vitro models from the laboratory to practical, real-world applications.